Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. was established in October 1996 and listed on the A-share main board of the Shanghai Stock Exchange in April 2015 with a registered capital of 849.16 million yuan. After more than 20 years of market economy and the baptism and tempering of the tide of reform and opening up, it has now developed into a large-scale pharmaceutical listed company integrating production, sales and research and development.